Eli Kalif
2020
In 2020, Eli Kalif earned a total compensation of $3.7M as Executive Vice President, Chief Financial Officer at Teva Pharmaceutical Industries, a 18,016% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $826,599 |
|---|---|
| Salary | $681,281 |
| Stock Awards | $1,949,974 |
| Other | $265,961 |
| Total | $3,723,815 |
Kalif received $1.9M in stock awards, accounting for 52% of the total pay in 2020.
Kalif also received $826.6K in non-equity incentive plan, $681.3K in salary and $266K in other compensation.
Rankings
In 2020, Eli Kalif's compensation ranked 3,104th out of 13,090 executives tracked by ExecPay. In other words, Kalif earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,104 out of 13,090 | 76th |
Division Manufacturing | 1,208 out of 5,621 | 79th |
Major group Chemicals And Allied Products | 461 out of 2,254 | 80th |
Industry group Drugs | 399 out of 1,954 | 80th |
Industry Pharmaceutical Preparations | 298 out of 1,459 | 80th |
Source: SEC filing on April 21, 2021.
Kalif's colleagues
We found four more compensation records of executives who worked with Eli Kalif at Teva Pharmaceutical Industries in 2020.
2020
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2020
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2020
Brendan O'Grady
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2020
Eric Drap
Teva Pharmaceutical Industries